IRF1 and neoplasm: Whereas IRF1 activation was increased in HEK293T and ER+ MCF-7 cells overexpressing HA-BCA2, its activation was decreased in ER– MDA-MB-231 and non-tumor MCF-12F cells (Figure 5E).